About the Company
Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
Sector
Health Care and Social Assistance
Industry
General Medical and Surgical Hospitals
Employees
7
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AVCO News
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
FREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today ...
Avalon Globocare Corp ALBT
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Avalon GloboCare launches KetoAir breathalyzer in the U.S.
FREEHOLD, N.J. - Avalon GloboCare Corp. (NASDAQ: ALBT), a biotechnology company specializing in cell-based technologies and diagnostics, announced today the U.S. launch of its KetoAir ...
ALBT Stock Earnings: Avalon Globocare Reported Results for Q4 2023
Avalon Globocare just reported results for the fourth quarter of 2023.More From InvestorPlace The #1 AI Investment Might Be ...
Latest News for Avalon Globocare Stock (NASDAQ:ALBT)
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ...
Avalon GloboCare extends exclusive distribution agreement for KetoAir breathalyzer
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you ...
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
FREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based ...
Avalon Globocare Corp ALBT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Avalon GloboCare extends KetoAir distribution agreement
FREEHOLD, N.J. - Avalon GloboCare Corp. (NASDAQ: ALBT), a biotechnology company focused on cellular therapeutics and diagnostics, has announced the expansion of its distribution partnership with Qi ...
Avalon GloboCare Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Avalon GloboCare Corp. Common Stock (ALBT)
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...
Loading the latest forecasts...